Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SIRT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NFKBIB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SARS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ECH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LGALS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LGALS7B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPN12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF3K - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on